Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

215
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>APOE</i> Genotype Modifies the Predictive Performance of Plasma Biomarkers for Amyloid Plaque Burden in Subjective Cognitive Decline.

Journal of Korean medical science·2026
Same author

Prediction of cognitive impairment through speech data analysis: A comparative evaluation of deep learning models.

PloS one·2026
Same author

A Novel Frameshift Mutation in <i>SLC20A2</i> in a Korean Patient with Primary Brain Calcification, Parkinsonism and Memory Impairment.

Biomedicines·2026
Same author

Plasma glial fibrillary acidic protein as a potential biomarker for differentiating amyloid-negative subjective cognitive decline and mild cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Same author

A Protocol of Korean JOint RegistrY for ALZheimer's Treatment and Diagnostics (JOY-ALZ).

Dementia and neurocognitive disorders·2026
Same author

Hand Grip Strength Predicts Cognitive Decline in Subjective Cognitive Decline: 2-Year Follow-up Results.

Journal of Korean medical science·2026

Related Experiment Video

Updated: Sep 21, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Neuropsychological test using machine learning for cognitive impairment screening.

Chanda Simfukwe1, SangYun Kim2, Seong Soo An3

  • 1Department of Neurology, College of Medicine, Chung-Ang University, Seoul, South Korea.

Applied Neuropsychology. Adult
|June 2, 2022
PubMed
Summary

Machine learning models accurately detect cognitive impairment and dementia using neuropsychological tests. Support vector machine (SVM) algorithms show high prediction accuracy, aiding clinicians in cognitive function assessment.

Keywords:
Cognitive impairmentconfusion matrixdementia diseasemachine learningsupport vector machine

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K
A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice
07:18

A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice

Published on: March 2, 2019

19.3K

Related Experiment Videos

Last Updated: Sep 21, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K
A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice
07:18

A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice

Published on: March 2, 2019

19.3K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Neuropsychological tests (NPTs) are crucial for assessing cognitive function but require specialized interpretation.
  • Interpreting NPTs can be time-consuming, necessitating efficient diagnostic tools.

Purpose of the Study:

  • To develop and evaluate machine learning models for detecting normal cognition (NC), cognitive impairment (CI), and dementia.
  • To assess the performance of Support Vector Machine (SVM) algorithms in classifying cognitive states using NPT data.

Main Methods:

  • Utilized a dataset of 14,927 subjects from the Seoul Neuropsychological Screening Battery (SNSB), including 44 NPTs, age, education, and diagnosis.
  • Trained supervised machine learning models using the SVM classifier 30 times to predict cognitive states (NC vs. CI, NC vs. dementia, NC vs. CI vs. dementia).
  • Evaluated model performance using accuracy, sensitivity, and specificity, with confusion matrices generated from the testing dataset.

Main Results:

  • The NC vs. dementia model achieved the highest mean accuracy (97.74% ± 5.78%), sensitivity (97.99% ± 5.78%), and specificity (96.08% ± 4.33%).
  • The model for distinguishing NC, CI, and dementia achieved a mean accuracy of 83.85% ± 4.33%.
  • SVM demonstrated suitability for imbalanced datasets, outperforming other algorithms in prediction accuracy.

Conclusions:

  • SVM-based machine learning models trained on NPT data can effectively assist neuropsychologists in classifying cognitive function.
  • The developed models show significant potential for improving the efficiency and accuracy of diagnosing cognitive impairment and dementia.
  • The study highlights the utility of AI in augmenting clinical decision-making for neurological disorders.